United States · FDA National Drug Code directory
Aripiprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-125_deb9183f-bf62-4547-9c33-b6d8af55ddd9
- Product NDC
- 33342-125
- Form
- TABLET
- Composition / generic term
- Aripiprazole
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161008
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (33342-125-07) · 33342-125-07
- 100 TABLET in 1 BOTTLE (33342-125-11) · 33342-125-11
- 10 BLISTER PACK in 1 CARTON (33342-125-12) / 10 TABLET in 1 BLISTER PACK · 33342-125-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →